CD45 targeting antibody targeted amanitin conjugates (Magenta)

N/A

Report date: 2025/03/19 11:37:20

Base Information

Drug NameCD45 targeting antibody targeted amanitin conjugates (Magenta)
Drug Alias NameCD45 targeting antibody targeted amanitin conjugates (Magenta/Heidelberg Pharma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionLeukocyte common antigen inhibitors
TargetsLeukocyte common antigen
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHeidelberg Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesMagenta Therapeutics Inc
Inactive CompaniesHeidelberg Pharma AG
Active IndicationsHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A